Post Archive by Month

Vaccine mandates have been used for over 150 years in the United States to preserve public health, wrote researchers in a new study published by the journal Vaccines.
Announced on July 28, 2023, this retrospective cohort study examined COVID-19 vaccine uptake before and after implementing a vaccine mandate among employees at a major academic hospital in Philadelphia, PA. 
In the 3.5 months between the mandate announcement to enforcement, COVID-19 vaccine completion rates for staff rapidly increased from 86% to 98.7%.

A recent Morbidity and Mortality Weekly Report published by the U.S. Centers for Disease Control and Prevention (CDC) confirmed the route of administration of the first dose of Bavarian Nordic JYNNEOS® (MVA-BN) vaccine was not associated with lower overall 2-dose series completion rates during the mpox outbreak in the U.S.

In 2008, the Swiss National AIDS Commission claimed that people infected with human immunodeficiency virus (HIV) adhering to effective antiretroviral therapy (ART) do not transmit HIV.
Subsequently, researchers examined this concept and other evidence for sexual HIV transmission risk linked to viral load. They found sexual HIV transmission absent in cases involving less than 600 copies per mL and exceedingly rare in cases of less than 1000 copies per mL.

Researchers recently used data from smartwatches and fitness trackers to investigate whether vaccination produces measurable changes in personal health and well-being.
The Corona-Datenspende-App was launched in April 2020 and, as of April 2022, was still being used by 190,000 users in Germany, 120,000 of which were submitting daily data on resting heart rate, physical activity, and sleep duration.
In addition, the app collects optional survey data on diagnostic test results and vaccination data.

Scientists are expected to present new data today about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV), offering one of the first snapshots of the interplay among these common but potentially deadly viruses. 
Announced on July 25, 2023, the research included results from more than 26,000 respiratory tests of U.S. adults and children in late 2022 and found co-infections in more than 1% of positive samples.

After several years of development, various countries will offer infants, pregnant women, and seniors therapeutic options to prevent respiratory syncytial virus (RSV) infections in 2023.
Driven by recent governmental authorizations, sales of RSV drugs are estimated to surpass $9 billion by 2029, a sizeable increase from the $1 billion forcasted by GlobalData plc in 2023.

While the world focused on one type of coronavirus for four years, another sub-type continues to impact people.
The United Arab Emirates (UAE) recently notified World Health Organization (WHO) of a case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Al Ain City in Abu Dhabi.
This is the UAE's 94th confirmed MERS case and 12th death since July 2013, which indicates this viral respiratory infection has a Case Fatality Ratio of no less than 13%.